EUVIMEDEUVIMED entdecken
Crossref

Women with type 2 diabetes have LDL cholesterol levels higher than those of men, regardless of their treatment and their cardiovascular risk level

Sylvain Paquet, Jeanne Sassenou, Virginie Ringa, Sébastien Czernichow, Marie Zins, Anna Ozguler, Laurent Rigal

Nutrition, Metabolism and Cardiovascular Diseases · 2023

DOI: 10.1016/j.numecd.2023.03.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2023. Verfasst von Sylvain Paquet und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Practice, University of Paris-Saclay, Paris, France; CESP (Centre for Research in Epidemiology and Population Health), Inserm U…. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Diabetes Mellitus, Type 2, Cardiovascular Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: Several works have shown that control of the principal cardiovascular risk factors, especially LDL-C, is poorer among women with type 2 diabetes than men with this disease. Our objectives were to compare the statin treatments and LDL-C levels between men and women with type 2 diabetes, according to the potency of the statin they take, while taking their cardiovascular risk level into account. METHOD AND RESULTS: This is a descriptive cross-sectional study within the French CONSTANCES cohort. At inclusion, each individual completed several self-administered questionnaires. Data were then matched to their health insurance fund reimbursement data. The study population comprises cohort members with pharmacologically treated type 2 diabetes. We identified 2541 individuals with type 2 diabetes; 2214 had an available LDL-C value. In the total sample, treatment by statins did not differ between men and women, while the women had a higher mean LCL-C level than men. The analyses stratified by cardiovascular risk showed that women at very high cardiovascular risk received significantly less frequent statin delivery than men (OR = 0.72 [0.56-0.92]; p = 0.01). At the same time, women received the same rate of high-potency statins as men. Women taking equivalently potent statins had significantly higher LDL-C levels than men did. CONCLUSION: For the same cardiovascular risk level and the same statin treatment, women had an LDL-C level higher than that of men. They thus present a residual cardiovascular risk that justifies intensification of their statin treatment if tolerance allows.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsDiabetes Mellitus, Type 2Cardiovascular DiseasesMaleHumansFemaleCholesterol, LDLCross-Sectional StudiesRisk FactorsTreatment OutcomeHeart Disease Risk Factors

Stichwörter der Autor:innen

CholesterolDiabetes mellitusGenderLipid lowering treatmentStatins

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsCholesterol, LDL

Autor:innen und Institutionen

  • Department of General Practice, University of Paris-Saclay, Paris, France; CESP (Centre for Research in Epidemiology and Population Health), Inserm U1018, Université Paris-Saclay, équipe soins primaires et prévention, V…
  • CESP (Centre for Research in Epidemiology and Population Health), Inserm U1018, Université Paris-Saclay, équipe soins primaires et prévention, Villejuif, France. Electronic address: virginie.ringa@inserm.fr.
  • Université de Paris, Paris, France; AP-HP, Service de Nutrition, Centre Spécialisé Obésité, Hôpital Européen Georges Pompidou, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR 1153,…
  • Inserm, Population-based Epidemiologic Cohorts Units, UMS 011, Villejuif, France. Electronic address: marie.zins@inserm.fr.
  • Inserm, Population-based Epidemiologic Cohorts Units, UMS 011, Villejuif, France. Electronic address: anna.ozguler@inserm.fr.

Zitieren

APA

Paquet, S., Sassenou, J., Ringa, V., Czernichow, S., Zins, M., Ozguler, A., & Rigal, L. (2023). Women with type 2 diabetes have LDL cholesterol levels higher than those of men, regardless of their treatment and their cardiovascular risk level. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2023.03.015

Vancouver

Paquet S, Sassenou J, Ringa V, Czernichow S, Zins M, Ozguler A, et al. Women with type 2 diabetes have LDL cholesterol levels higher than those of men, regardless of their treatment and their cardiovascular risk level. Nutrition, Metabolism and Cardiovascular Diseases. 2023. doi:10.1016/j.numecd.2023.03.015

BibTeX
@article{Paquet2023,
  author = {Paquet, Sylvain and Sassenou, Jeanne and Ringa, Virginie and Czernichow, Sébastien and Zins, Marie and Ozguler, Anna and Rigal, Laurent},
  title = {Women with type 2 diabetes have LDL cholesterol levels higher than those of men, regardless of their treatment and their cardiovascular risk level},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2023},
  doi = {10.1016/j.numecd.2023.03.015}
}
Kostenlos starten →